DAIICHI SANKYO Aktie
| 13,71EUR | -0,08EUR | -0,58% |
WKN: A0F57T / ISIN: JP3475350009
Personal
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 16 458 | 17 435 | 18 726 | 19 765 | 20 171 |
| Umsatz pro Mitarbeiter in Mio. EUR | 63,49 | 73,33 | 85,53 | 95,43 | 105,25 |
Bilanz (in Mio. JPY) - Aktiva
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 345 271 | 1 495 051 | 2 174 024 | 1 909 433 | 2 142 509 |
| Summe Anlagevermögen | 876 131 | 1 013 838 | 1 287 111 | 1 546 686 | 1 862 881 |
| Summe Aktiva | 2 221 402 | 2 508 889 | 3 461 135 | 3 456 119 | 4 005 390 |
Bilanz (in Mio. JPY) - Passiva
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 870 526 | 1 063 031 | 1 772 527 | 1 832 698 | 2 341 206 |
| Summe Eigenkapital | 1 350 872 | 1 445 854 | 1 688 602 | 1 623 416 | 1 664 179 |
| Summe Passiva | 2 221 398 | 2 508 885 | 3 461 129 | 3 456 114 | 4 005 385 |
Adresse
| Daiichi Sankyo Head Office Bldg, A&B, 103-8426 Tokyo | |
| Telefon | +81 (3) 6225-1111 |
| Internet | https://www.daiichisankyo.co.jp |
Management
|
Abe Yusei
General Manager-Research & Development |
|
Akihiro Watanabe
Independent Outside Director |
|
Akio Sakurai
Executive Officer |
|
Chiaki Matsumoto
Executive Officer & GM-Medical Affair |
|
Hiroyuki Okuzawa
President, CEO & Representative Director |
|
James Felix
Chief Digital Transformation Officer |
|
John Tsai
Global Head-Research & Development |
|
Kenneth Joseph Keller
Director & Head-Oncology Business Unit |
|
Matt Allegrucci
Chief Compliance Officer & Head-Risk |
|
Miyuki Arai
Auditor |
|
Naoki Shimizu
Chief Quality Officer |
|
Naoto Tsukaguchi
General Counsel, Head-Global Legal & IP |
|
Nobuo Murakami
Chief Strategy Officer |
|
Reiko Kinoshita
Independent Outside Director |
|
Shangdai Cai
Head-Global Compliance & Risk Management |
|
Stuart J. Mackey
Head-Global Business Development |
|
Takaaki Nishii
Independent Outside Director |
|
Takashi Matsumoto
Senior MD & Chief Human Resources Officer |
|
Terumichi Yokoyama
Auditor |
|
Tomohiro Kodama
Chief Financial Officer & Senior Executive Officer |
|
Ueno Shizuko
Director & Head-Medical Affairs |
|
Yasuhiro Komatsu
Independent Outside Director |
|
Yo Honma
Independent Outside Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.